BSE filing, NSE: DWARKESH. Summary written from the filing by ALFA Finder's alert engine.
Dwarikesh Sugar Industries Ltd: key numbers
- Share price
- ₹41.29
- Market cap
- ₹765.1 Cr
- Revenue (annual)
- ₹1,402 Cr
- Net profit (annual)
- ₹30.84 Cr
- P/E (TTM)
- 52.8×Sector 26.2×
- Promoter holding
- 42.14%+0.00% QoQ
- FII holding
- 1.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dwarikesh Sugar Industries Ltd
All →Dwarikesh Sugar Industries Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 2,565.9m (+4.3% YoY); loss narrowed to Rs 131.2m from Rs 326.2m on higher sugar realisation (Rs 4,530.6/qtl). H1 loss Rs 388.5m; nil crushing hurt volumes.
Dwarikesh Sugar Industries Results Update
Dwarikesh Sugar posted a Q2 FY27 loss of ₹13.12 crore, improved from the prior-year quarter. Crushing for the 2026-27 season is set to begin in November.
Dwarikesh Sugar Industries Annual General Meeting
Dwarikesh Sugar fixed a November 13, 2026 record date for a postal ballot on director continuations. The resolutions cover two independent directors attaining age 75.
Dwarikesh Sugar Industries Q2 FY27 Results: Net Loss of ₹13.1 Cr, Loss Narrows
Dwarikesh Sugar Industries Ltd reported revenue from operations of ₹256.6 Cr (+4.4% YoY) and a net loss of ₹13.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹13.1 Cr
Dwarikesh Sugar Industries Board Meeting Date
Dwarikesh Sugar intimated its Board meeting scheduled for October 29, 2026. The agenda covers Q2 FY27 unaudited results and independent director continuations.
Dwarikesh Sugar Industries Credit Rating
ICRA withdrew Dwarikesh Sugar's A1 rating on its ₹300 crore Commercial Paper at the company's request. Long-term A+ (Stable) ratings on ₹600 crore facilities were re-affirmed.
Other other announcement announcements
All →Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.
Shri Gang Industries and Allied Products Other Announcement
Shri Gang Industries filed its quarterly shareholding pattern dated 23 October 2026. The filing notes pledges, a warrant conversion, and a deceased promoter's shares moved to a nominee.